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Abstract Variants in NDUFB11, which encodes a structural component of complex I of the
mitochondrial respiratory chain (MRC), were recently independently reported to cause
histiocytoid cardiomyopathy (histiocytoid CM) and microphthalmia with linear skin
defects syndrome (MLS syndrome). Here we report an additional case of histiocytoid CM,
which carries a de novo nonsense variant in NDUFB11 (ENST00000276062.8: c.262C > T;
p.[Arg88∗]) identified using whole-exome sequencing (WES) of a family trio. An identical
variant has been previously reported in association with MLS syndrome. The case we
describe here lacked the diagnostic features of MLS syndrome, but a detailed clinical
comparison of the two cases revealed significant phenotypic overlap. Heterozygous
variants in HCCS (which encodes an important mitochondrially targeted protein) and
COX7B, which, like NDUFB11, encodes a protein of the MRC, have also previously been
identified in MLS syndrome including a case with features of both MLS syndrome and
histiocytoid CM. However, a systematic review of WES data from previously published
histiocytoid CM cases, alongside four additional cases presented here for the first time,
did not identify any variants in these genes. We conclude that NDUFB11 variants play a
role in the pathogenesis of both histiocytoid CM and MLS and that these disorders are
allelic (genetically related).
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INTRODUCTION
NDUFB11 (OMIM ∗300403) variants have recently been independently proposed to cause
histiocytoid cardiomyopathy (histiocytoid CM; OMIM 500000) (Shehata et al. 2015) and
microphthalmia with linear skin defects syndrome (MLS; OMIM 309801) (van Rahden et al.
2015). Histiocytoid CM is a rare, distinctive form of cardiomyopathy with approximately
150 cases reported worldwide, it has numerous synonyms including oncocytic cardiomyop-
athy (Shehata et al. 2011). Predominantly affecting females early in life, it is characterized by
arrhythmias and associated sudden death (Gilbert-Barness and Barness 2006). Associated
cardiac abnormalities include ventricular and atrial septal defects, endocardial fibroelastosis,
and hypoplastic left heart syndrome (Shehata et al. 1998). Extracardiac features involving the
nervous system and eyes are also frequently reported (Malhotra et al. 1994). Variants in mi-
tochondrial DNA (mtDNA) have previously been associated with histiocytoid CM (Vallance
et al. 2004), but this has not been replicated in further studies. Histological findings in cardiac
tissue often show an accumulation of excessive, aberrantly shapedmitochondria, supporting
the role of mitochondrial dysfunction in the etiology (Shehata et al. 2015).
MLS syndrome, also known as MIDAS syndrome (microphthalmia, dermal aplasia, and
sclerocornea) (Happle et al. 1993), was first described in 1988 (Al-Gazali et al. 1988). It is a
rare X-linked disorder with male lethality in utero, characterized by unilateral or bilateral
microphthalmia and linear skin defects. Skin defects are classically limited to the face
and neck along Blaschko’s lines, are present from birth, and heal with time, often leaving
minimal scarring. Additional clinical features may include neurological and cardiac abnor-
malities (Morleo and Franco 1993). Heterozygous variants in the X-encoded genes HCCS
(OMIM ∗300056) (Wimplinger et al. 2006), which encodes an important mitochondrially tar-
geted protein, and COX7B (OMIM ∗300885) (Indrieri et al. 2012), which encodes a compo-
nent of the mitochondrial respiratory chain (MRC), have been identified previously in MLS-
affected females (Indrieri et al. 2012). However, variants are not detected in all cases, sug-
gesting genetic heterogeneity.
More than 20 years ago, Bird and coworkers reported an infant with the characteristic skin
lesions of the then newly recognized MLS syndrome and a normal 46, XX karyotype, who
died suddenly and unexpectedly at 4 mo of age. Death was attributed to oncocytic (histio-
cytoid) cardiomyopathy (Bird et al. 1994). The authors noted that the “coexistence of two
rare conditions, one of which mapped to the X Chromosome, and an excess of affected fe-
males with oncocytic cardiomyopathy, make it likely that oncocytic cardiomyopathy is also X-
linked, with Xp22 being a candidate region. Overlapping manifestations in the two condi-
tions (ocular abnormalities in cases of oncocytic cardiomyopathy and arrhythmias in MLS) of-
fer additional support for this hypothesis” (Bird et al. 1994). Here, we present evidence in
support of the allelic nature of these conditions. We describe a new case of histiocytoid
CM in whom we identified a de novo nonsense variant inNDUFB11 (c.262C > T; p.(Arg88∗))
(see Table 1). An identical variant has recently been reported as the molecular basis of a case
of MLS syndrome.We compare the clinical features of these cases (see Table 2), highlighting
that although each of the two entities show distinct manifestations, they share substantial
phenotypic overlap and potential mechanisms are outlined.
RESULTS
The trio sequencing approach identified two rare de novo variants, predicted to be protein
altering in the proband: NDUFB11 c.262C > T; p.(Arg88∗) and FAM135A c.474C >G;
p.(Tyr158∗). Sanger sequencing confirmed the presence of both variants in the affected
child and their absence in the unaffected parents (see Fig. 1). NDUFB11 was a highly
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plausible candidate gene, located on the X Chromosome, providing a potential mechanism
for the predominance of females affected (with presumed in utero male lethality), with a
mitochondrial function in keeping with previous understanding of histiocytoid CM as a mi-
tochondrial disorder. Alternative inheritance models (monoallelic or biallelic) were consid-
ered with no additional strong candidate genes identified. We interrogated four additional
unrelated cases of histiocytoid CM for variants in NDUFB11, COX7B, or HCCS, and no pu-
tative disease-causing variation was identified. We also reviewed publicly available WES
data (Shehata et al. 2015) from three additional cases of histiocytoid CM without
NDUFB11 variants and found no evidence of de novo or rare variants in either HCCS or
COX7B.
DISCUSSION
At the outset of our study themolecular etiology of histiocytoid CMwas unknown; we under-
took WES in a trio involving an affected child (see Fig. 2) and both unaffected parents. This
identified a de novo nonsense variant inNDUFB11, an X-encoded mitochondrial gene, con-
sistent with the suspected role of mitochondrial dysfunction in histiocytoid CM (Ferrans et al.
1976) and a de novo nonsense variant in FAM135A.
Simultaneous to our analyses, two independent reports showed evidence of variants in
NDUFB11 associated with histiocytoid CM (Shehata et al. 2015) and MLS syndrome (van
Rahden et al. 2015). The phenotypic associations of these additional variants in NDUFB11
and ours are shown in Table 3. An identical variant to that reported here has recently
been reported in a case of MLS in whom histiocytoid CM was found postmortem (van
Rahden et al. 2015) indicating a sharedmolecular basis for these conditions. Our case lacked
the diagnostic features of MLS syndrome (see Table 2). Although FAM135Awas not formally
excluded as a candidate, there was no additional evidence to implicate a role for it in histio-
cytoid CM.
Seventy five percent of cases of histiocytoid CM present in female infants (Shehata et al.
2015), often below 2 yr of age (Gilbert-Barness and Barness 2006), and the identification of
NDUFB11, found on Xp11.23, as an underlying cause explains the large excess of affected
females. There have been no molecular reports yet to confirm this as a cause of embryonic
male lethality, although Shehata and coworkers comment it is “tempting to speculate that
similar mutations occurring in males are embryonic lethal and cause miscarriage, since there
would be no residual protein activity” (Shehata et al. 2015).
Table 1. Summary of variant of interest in NDUFB11
HGNC symbol NDUFB11
Name NADH:ubiquinone oxidoreductase subunit B11
Genomic location
GRCh37 (hg19)
Chromosome X: 47002089
HGVS cDNA ENST00000276062.8 c.262C> T
HGVS protein p.(Arg88∗)
Predicted effect Stop gained
Genotype Heterozygous
Inheritance mode Sporadic
Frequency in ExAC 0
HGNC, HUGO Gene Nomenclature Committee; HGVS, Human Genome Variation Society; ExAC, Exome Aggregation
Consortium.
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There is evidence for genetic heterogeneity in histiocytoid CM, as variants in NDUFB11
and other candidate genes described here do not explain all cases. We hypothesize that
HCCS (OMIM 30056) and COX7B (OMIM 300885), which are X-linked genes encoding or
targeting mitochondrial proteins and are implicated in MLS, are good candidate genes for
Table 2. Detailed comparison of the clinical features of two individuals with the same NDUFB11 truncating
variant (ENST00000276062.8: c.262C > T; p.(Arg88∗))—one manifesting primarily as histiocytoid CM, the
other with microphthalmia and linear skin defects syndrome
Phenotypic feature Case described here (Case 1)
Case reported by
van Rahden et al. 2015
Presenting phenotype Histiocytoid CM Microphthalmia and linear skin
defects syndrome
Antenatal history Healthy, nonconsanguineous parents Healthy, nonconsanguineous parents
Alternating bradycardia and
tachycardia noted at 27 wk;
emergency Cesarean section at 38
wk for fetal tachycardia
Sex Female Female
Birth weight 3690 g (91st centile) 3060 g (10th–25th centile)
Cardiac arrhythmias Neonatal episodes of supraventricular
tachycardia; collapse with first
documented ventricular tachycardia
(VT) at 7 mo; continued VT
“storms” necessitating drug
treatment, dual chamber
implantable cardiac defibrillator,
and left thoracic sympathectomy;
cardiac transplantation was carried
out at 13 mo
Sudden unexpected cardiac arrest
aged 6 mo; repeated treatment for
ventricular arrhythmias; death within
several weeks
Cardiomyopathy Features of left ventricular
noncompaction; preserved systolic
function
Nil reported
Cardiac histology Histiocytoid CM Histiocytoid CM
Eye abnormalities
Microphthalmia
Scleroderma
Other eye
abnormalities
Not present
Not present
Intermittent squint
Nil reported
Nil reported
Lacrymal duct atresia
Neuromuscular Mild-to-moderate bulbar palsy Axial hypotonia present from birth
Skin abnormalities None present Linear skin defects on nose, chin, and
neck present at birth, disappeared
in the first few months of life
Thyroid abnormalities Focal histiocytoid change in the
thyroid (and also lungs and choroid
plexus of the brain)
Oncocytic metaplasia evidence on
postmortem
Other anomalies Severe feeding difficulties
gastroesophageal reflux, requiring
Nissen fundoplication and
percutaneous endoscopic
gastrostomy
Failure to thrive documented from 1
mo of age
Evidence of somatic
mosaicism
No evidence in DNA from
lymphocytes
Yes, in DNA from lymphocytes and
fibroblasts
CM, cardiomyopathy.
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Figure 1. (A) Sequence electropherogram from genomic DNA of child affected by histiocytoid cardiomyop-
athy (CM) from the family trio showing theNDUFB11 variant identified by whole-exome sequencing (WES) and
confirmed by Sanger sequencing. The image shows part of NDUFB11 exon 2. Forward and reverse reads are
shown. The red arrows point to the double peak in the electropherogram showing heterozygosity for the non-
sense variant inNDUFB11 c.262C> T. The next-generation sequencing (NGS) coverage at this base was 62×,
with 27 reference reads and 33 alternate reads. (B) Sequence electropherogram from genomic DNA of the un-
affected mother from the trio showing no evidence of the NDUFB11 sequence-level variant that had been
identified in the affected child. The image shows part of NDUFB11 exon 2. Forward and reverse reads are
shown. The red arrows point to the base where the nonsense variant in NDUFB11 c.262C > T was detected
in the affected daughter. The coverage at this base on WES was 50×, with no evidence of the variant. (C )
Sequence electropherogram from genomic DNA of the unaffected father from the trio showing no evidence
of the NDUFB11 variant that was identified in the affected child. The image shows part of NDUFB11 exon
2. Forward and reverse reads shown. The red arrows point to the base where the nonsense variant in
NDUFB11 c.262C > T was detected in the affected daughter. The coverage at this base on WES was 26×,
with no evidence of the variant.
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histiocytoid CM. We note that van Rahden et al. (2014) have reported previously a female
child with a de novo HCCS nonsense variant (c.589C > T; p.(R197∗)) and extremely skewed
X-inactivation (98:2) with classical features of MLS including linear skin defects on her neck,
microphthalmia, anophthalmia, and sclerocornea, who died at 4 mo with ventricular tachy-
cardia (VT) and was found to have histiocytoid CM on postmortem examination, further sup-
porting that MLS and histiocytoid CM are allelic disorders. However, no rare variants were
found in HCCS or COX7B in seven additional histiocytoid CM cases without NDUFB11 var-
iants (four described here, three in Shehata et al. 2015), though this small series does not ex-
clude a role in “isolated” histiocytoid CM.
Comparisons (see Table 2) between the phenotype in the case of histiocytoid CM pre-
sented here and the case of MLS with an identical NDUFB11 variant (van Rahden et al.
2015) show considerable phenotypic overlap. The case of MLS also had histiocytoid CM;
a feature only identified on postmortem examination. The vast majority of cases of histiocy-
toid CM are identified postmortem or on examination of the native explanted heart during
cardiac transplantation. It is possible that additional cases of MLS also have histiocytoid CM
but it remains undetected, as has previously been reported (Bird et al. 1994). Previously there
was no specific clinical indication to perform detailed cardiac phenotyping in MLS and so
further data are lacking. Wimplinger et al. 2006 reported a female, born to healthy noncon-
sanguineous parents after an uneventful pregnancy, found to have bilateral microphthalmia
and sclerocornea but no erythematous skin lesions. She had a de novo HCCS nonsense var-
iant (c.589C > T; p.(R197∗)) that was also reported in an additional case with both MLS and
histiocytoid CM (van Rahden et al. 2014). Around 1 yr of age she was reported to have de-
veloped “idiopathic VT” (Wimplinger et al. 2006). In the absence of cardiac histology a diag-
nosis of histiocytoid CM cannot be confirmed, but we suggest it could underlie her VT.
Wide intra- and interfamilial variation in MLS is recognized including carrier females with
variants in HCCS or NDUFB11 (see Table 2) or terminal Xp deletions but no clinical features
of MLS syndrome (van Rahden et al. 2015). There are several potential explanations for the
wide phenotypic variation including somatic mosaicism; in their case of MLS (see Table 2)
van Rahden and coworkers noted that themutated base thyminewas present in 42 sequence
reads and the wild-type base cytosine in 84, suggesting that the variant was present in mo-
saic state in lymphocytes. DNA isolated from fibroblasts was also suggestive of mosaicism
Figure 2. Histology of histiocytoid cardiomyopathy. Longitudinal section of myocardium from an infant with
histiocytoid cardiomyopathy. A few normal myocytes are present in the lower part of the field. The remaining
cells are histiocytoid myocytes.
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Table 3. Catalog of variants reported in NDUFB11, with associated phenotypes
Case 1 Case 2 Case 3a Case 4a Case 5a Case 6 Case 7
Reported
diagnosis
Histiocytoid
CM
MLS
syndrome
MLS syndrome Asymptomatic Terminated
pregnancy at
24th wk
gestation
Histiocytoid
CM
Histiocytoid
CM
Sex Female Female Female Female Female Female Female
Cardiac
phenotype
Histiocytoid
CM
Histiocytoid
CM
Developed dilated
cardiomyopathy
at 2 mo of age
requiring heart
transplant at 6
mo of ageb
Nil reported Thickened
myocardium
Pericardial effusion
Histiocytoid
CM
Histiocytoid
CM
Eye
phenotype
Intermittent
squint
Lacrimal duct
atresia
Myopia, nystagmus,
and strabismus
Nil reported Nil reported Nil reported Nil reported
Skin
phenotype
Nil Linear skin
defects on
nose, chin,
and neck
present at
birth
Linear and atrophic
hyperpigmented
streaks on face
and neck
Nil reported Nil reported Nil reported Nil reported
Protein
variantc
p.(Arg88∗) p.(Arg88∗) p.(Arg134Serfs∗3) p.(Arg134Serfs∗3) p.(Arg134Serfs∗3) p.(Trp85∗) p.(Tyr108∗)
Genomic
coordinated
47002089 47002089 47001806 47001806 47001806 47002097 47002027
Exon Exon 2 Exon 2 Exon 3 Exon 3 Exon 3 Exon 2 Exon 2
Status De novo De novo Inherited from
asymptomatic
mother
Unknown Inherited from
asymptomatic
mother
De novo De novo
Other
phenotypic
features
Bulbar palsy
Severe
feeding
difficulties
Seizures
Developmental
delay
Agenesis of the
corpus callosum
Severe muscular
hypotonia
Delayed dentition
Growth parameters
below the 3rd
centile at 15/12
Intra-uterine
growth
retardation
Dysgenesis of the
corpus callosum
Small cerebellum
Connection
between a lateral
ventricle and the
cavum septum
pellucidum
Reference Case
presented
here
Subject 1e Subject 2e Mother of
Subject 2e
Aborted fetus from
the mother of
subject 2e
GHC-Gf GHC-Tf
CM, cardiomyopathy; MLS, microphthalmia with linear skin defects.
aThree cases are from a single pedigree and they also have a heterozygous deletion of at least 70 kb at 2p16.3, containing part of NRXN1, which may have
influenced the phenotype. Intragenic mutations and deletions of NRXN1 are enriched in cohorts with neurodevelopmental and autistic spectrum disorders.
Incomplete penetrance is reported.
bNo evidence of histiocytoid CM reported, although further review of histology in light of current knowledge would be of interest.
cENST00000276062.8.
dGRCh37(hg19).
evan Rahden et al. 2015.
fShehata et al. 2015.
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(van Rahden et al. 2015). In addition, Shehata et al. (2015) note that in one of their cases with
a nonsense NDUFB11 variant (case GHCG) a second nonsense variant was detected in cy-
tochrome b, but only at a frequency of 20% and only in the cardiac tissue, possibly indicating
a clonal selection of a somatic variant in the diseased heart. The authors suggest this is one of
the potential avenues through which the expressivity of defects in MRC complex 1 activity
might be regulated (Shehata et al. 2015). X-inactivation may also influence phenotypic var-
iability as the majority of MLS-affected females have severe skewing of X Chromosome inac-
tivation suggesting that variants in causative X-linked gene(s) cause selective loss of cells in
which the mutated X Chromosome is active (van Rahden et al. 2015). Other causes of phe-
notypic variability could include copy-number variation or common or rare modifier variants
contributing to mitochondrial function (Shehata et al. 2015). Furthermore, phenotypic vari-
ability may reflect differing abilities of developing tissues and organs in embryonic cells to
handle a defective MRC system (van Rahden et al. 2014).
Conclusion
We conclude that variants inNDUFB11 are an important cause of histiocytoid CM and report
that histiocytoid CM and MLS, which are genetically heterogeneous, are allelic disorders.
However, many histiocytoid CM cases remain unexplained by known genes, suggesting a
heterogeneous genetic architecture with further contributing genes remaining to be discov-
ered. Histiocytoid CM typically affects female infants <2 yr of age and the identification of
NDUFB11, which is found on the chromosome band Xp11.23, as an underlying cause ex-
plains the large excess of affected females. Comparison of the phenotypes of histiocytoid
CM and MLS shows both considerable overlap and features specific to each entity.
Differences in phenotypic expression may be due to patterns of X-inactivation, somatic mo-
saicism, presence of additional variants, environmental factors, or epigenetic factors. We
suggest that individuals with MLS syndrome or variants or cytogenetic abnormalities involv-
ing NDUFB11, HCCS, or COX7B should be considered at risk for histiocytoid CM and
screening for evidence of malignant arrhythmias and cardiomyopathy may be appropriate.
Additional nuclear encoded or mtDNA genes within the MRC are good candidates for fur-
ther causes of both histiocytoid CM and MLS syndrome.
METHODS
Samples
An infant with histiocytoid CM and both unaffected parents were recruited through the NIHR
Cardiovascular Biomedical Research Unit at the Royal Brompton and Harefield NHS
Foundation Trust. Four additional biologically unrelated histiocytoid cardiomyopathy pro-
bands were recruited via U.K. regional genetics services. Studies were performed according
to institutional guidelines, with ethical approval.
Whole-Exome Sequencing Using a Trio Approach
The trio (of affected child and both unaffected parents) underwent WES using the Agilent
SureSelect system (Human All Exon v4 + UTR kit) with Illumina sequencing (HiSeq 2500,
100-bp paired-end). Reads were aligned to the human reference genome (hg19) using
Burrows–Wheeler alignment (BWA) (Li and Durbin 2009) v0.7.5, and variants were called us-
ing the Genome Analysis Toolkit (GATK) v2.8-1 software package (McKenna et al. 2010) ac-
cording to GATK Best Practice recommendations (DePristo et al. 2011; Van der Auwera et al.
2013). In the affected child, mother, and father, WES generated 11.9 gigabases (Gb), 9.1 Gb
and 10.4 Gb of data, respectively. The percentage callable was 99.4, 97.8, and 99.1,
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respectively (see Table 4). Variants were prioritized using the open source software platform
xBrowse (https://atgu.mgh.harvard.edu/xbrowse). Only variants that passed standard GATK
filters, with genotype quality score >20, coverage >20×, and allelic balance >20, were in-
cluded in the analysis. We filtered for rare (minor allele frequency [MAF] <0.001 in Exome
Aggregation Consortium [ExAC], 1000 Genomes, and xBrowse reference samples) de
novo variants, predicted to be protein altering (nonsense, frameshift, essential splice site,
missense, and in-frame insertion or deletion) in the proband. All inheritance models were
considered.
Sanger Sequencing of NDUFB11
The coding exons and intron–exon boundaries of NDUFB11 were amplified by polymerase
chain reaction (PCR), and directly sequenced using the BigDye Terminator Cycle
Sequencing Kit and an ABI3500Genetic Analyzer (Applied Biosystems). Sequences were an-
alyzed using Sequencher (v5.3) software. The coding sequence of all samples was fully cov-
ered in both directions.
Sequencing Primers
The sequencing primers were, for NDUFB11, F-TCCAGCCATGACTAGAGCTG, R-TCATC
TCAGCTCCCCATTCC, and for FAM135A, F-GTTGTACTGCAGCCTTGTAATAAAC, R-
CAGCCTGAAGAACCATGACC.
ADDITIONAL INFORMATION
Data Deposition and Access
NDUFB11 (SCV000297804.1) and FAM135A (SCV000297805.1) variants have been submit-
ted to ClinVar (htpp://www.ncbi.nlm.nih.gov/clinvar/). We do not have consent frompatients
to deposit complete sequencing data in a repository.
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provided written informed consent.
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Table 4. Summary figures of coverage for WES in each sample of the family trio
Sample Total reads
Mapped
reads
Percentage
mapped
Percentage
on target
Bases
10 ×
Bases
20×
Bases
30×
Percentage
callable
Mean
coverage
Median
coverage
Affected child 11,906,7512 118,785,553 99.8 81.7 97.8 93.4 87.6 99.4 113 89
Unaffected father 91,775,652 91,571,480 99.8 69.4 91.9 80.5 70.0 97.8 74 53
Unaffected mother 103,827,148 103,582,562 99.8 82.8 98.7 96.5 90.2 99.1 101 77
The trio consists of a child affected with histiocytoid cardiomyopathy and both unaffected parents. Figures are for the coverage of the protein-coding target.
Sequencing was undertaken using SureSelect Human All Exon V4 + UTR design (71 Mb) and the Illumina HiSeq 2500 platform.
WES, whole-exome sequencing.
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